Submit a Digital Poster on CHS
Cannabinoid hyperemesis syndrome (CHS) is an emergent public health challenge that is severely understudied. If you have any information about CHS that you want to share with others during our event, consider submitting an abstract to the 2026 ADAI Symposium describing your idea for a digital poster.
We’ll be projecting the posters onscreen during the Symposium lunch break and will publish them on the ADAI website along with the recordings from the Symposium.
Given the emerging and understudied nature of CHS and the limited literature available, small sample sizes, pilot studies, and early-stage research are highly encouraged. Submissions from clinicians, researchers, public health professionals, and interdisciplinary teams are welcome.
Deadline for abstract submission: August 18, 2026.
Send your abstract with the subject line “Poster submission for ADAI Symposium” to adai@uw.edu.
Acceptance: You will be notified of acceptance by August 29th. In case of acceptance, you must submit a poster as a single PowerPoint slide. Guidelines for slide layout/design can be found here (pdf, opens in new tab).
Scope of submissions
We welcome abstracts from clinical, research, and interdisciplinary perspectives, including but not limited to:
- Clinical Research: Case reports and case series, retrospective or prospective clinical studies, diagnostic challenges and misdiagnosis, treatment approaches (e.g., capsaicin, haloperidol, behavioral interventions), emergency medicine and inpatient care experiences
- Public Health & Epidemiology: Health disparities and equity, healthcare utilization (e.g., repeat ED visits), cannabis policy implications
- Behavioral & Social Sciences: Patient experiences and lived experience studies, qualitative research (interviews, focus groups), barriers to diagnosis or care
- Surveys & Educational Research: Clinician knowledge or awareness surveys; patient awareness studies; training, education, or intervention evaluations
- Other Relevant Contributions: Toxicology, gastroenterology, addiction medicine, health systems research, interdisciplinary or novel approaches
Abstract submission guidelines
- Word limit: 250–300 words
- No tables, figures, or references unless explicitly requested
- Use standard abbreviations and define on first use
- Title maximum ~20 words
- List all authors with institutional affiliations
- Include contact email
- Indicate IRB approval or exemption where applicable
- Confirm that patient confidentiality is maintained (e.g., for case reports, ensure no identifiable information is included)
Questions? Contact us at adai@uw.edu (please put “ADAI Symposium” in your subject line).
The ADAI Symposium is funded by the University of Washington’s Cannabis Dedicated Account.
